VANCOUVER, BC, Aug. 26, 2021 /CNW/ – MYND Life Sciences Inc. (CSE: MYND) (OTC: MYNDF) (“MYND” or the “Company“), is pleased to announce that it has entered into a binding term sheet in respect of a non-brokered private placement offering (the “Offering“) of debenture units (the “Debenture Units“) with a strategic institutional investor. The principal sum of the Debentures Units to be issued is up…


Previous articleMINDCURE Reaches Milestone, Releasing First of its Kind Mental Health Digital Therapeutics Platform to Partner Clinics in North America
Next articlePsilera Collaborates with the National Institute on Drug Abuse (NIDA) to Research DMT and New Analogues to Combat Addiction